Khảo Sát Toàn Bộ Gen Về Các Loci Liên Kết Với Nồng Độ Glucose Và HbA1c Trong Một Mẫu Dân Cư Căn Cứ Người Da Trắng

Diabetes - Tập 51 Số 3 - Trang 833-840 - 2002
James B. Meigs1, Carolien Panhuysen2, Richard H. Myers3, Peter W.F. Wilson4,5, L. Adrienne Cupples2
1General Internal Medicine and Clinical Epidemiology Units, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
2Department of Epidemiology and Biostatistics, Boston University School of Public Health and School of Medicine, Boston, Massachusetts
3Department of Neurology, Boston University School of Medicine, Boston, Massachusetts
4Boston University School of Medicine, Boston, Massachusetts
5Framingham Heart Study, Framingham, Massachusetts

Tóm tắt

Các mức glucose trong máu cao là dấu hiệu chính của bệnh tiểu đường loại 2 cũng như là một yếu tố nguy cơ mạnh mẽ cho sự phát triển của bệnh này. Chúng tôi đã thực hiện một cuộc tìm kiếm toàn bộ gen cho các gen liên quan đến bệnh tiểu đường, sử dụng các đo lường về glycémie như là các đặc điểm định lượng trong 330 gia đình từ Nghiên Cứu Tim Mạch Framingham. Trong số 3,799 người tham gia tại chu kỳ kiểm tra thứ 5 của Nghiên Cứu Hậu Duệ (1991–1995), 1,461, 1,251 và 771 nam (49%) và nữ đã cung cấp thông tin về mức glucose nhịn ăn trung bình 20 năm, glucose nhịn ăn hiện tại, và HbA1c, tương ứng, và 1,308 người đã đóng góp dữ liệu kiểu gen (sử dụng 401 chỉ thị vi nhân với khoảng cách trung bình 10 cM). Các mức của các đặc điểm glycémique đã được điều chỉnh cho tuổi, việc hút thuốc lá, sử dụng rượu và estrogen, hoạt động thể chất và chỉ số khối cơ thể (BMI). Chúng tôi đã xếp hạng các sai số chuẩn hóa từ các mô hình này, tạo ra các độ lệch chuẩn hóa từ các hạng, và sử dụng mô hình thành phần phương sai được triển khai trong SOLAR (Quy trình Phân tích Liên kết Oligogenic Tuần tự) để đánh giá liên kết với các độ lệch chuẩn hóa như là các đặc điểm định lượng. Chúng tôi tìm thấy bằng chứng đạt đỉnh cho liên kết với các mức glucose nhịn ăn trung bình 20 năm trên nhiễm sắc thể 1 tại khoảng 247 cM từ p-telomere (pter) (logarithm của nguy cơ nhiều điểm [LOD] 2.33) và trên nhiễm sắc thể 10 tại khoảng 86 cM từ pter (LOD nhiều điểm 2.07); với các mức glucose nhịn ăn hiện tại trên nhiễm sắc thể 1 tại khoảng 218 cM từ pter (LOD nhiều điểm 1.80) và trên nhiễm sắc thể 10 tại khoảng 96 cM từ pter (LOD nhiều điểm 2.15); và đối với các mức HbA1c trên nhiễm sắc thể 1 tại khoảng 187 cM (LOD nhiều điểm 2.81). Phân tích này của các gia đình châu Âu không chọn lọc gợi ý việc xác định các loci đặc điểm định lượng ảnh hưởng đến cân bằng glucose trên các nhiễm sắc thể 1q và 10q. Các phát hiện tại khoảng 187–218 cM trên nhiễm sắc thể 1 dường như lặp lại các liên kết đã được báo cáo trong các nghiên cứu trước đây của các quần thể khác, chỉ ra rằng vùng nhiễm sắc thể lớn này cần được xem xét kỹ lưỡng hơn trong việc tìm kiếm các gen nhạy cảm với bệnh tiểu đường loại 2.

Từ khóa

#tiểu đường loại 2 #glucose #HbA1c #gen #nhiễm sắc thể #nghiên cứu di truyền

Tài liệu tham khảo

American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes 20: 1183–1197, 1997

Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF: Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46:701–710, 1997

Nathan DM, Singer DE, Hurxthal K, Goodson JD: The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 310:341–346, 1984

Meigs JB, Nathan DM, Cupples LA, Wilson PWF, Singer DE: Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epi 49:411–417, 1996

Meigs JB, Nathan DM, Wilson PWF, Cupples LA, Singer DE: Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance: the Framingham Offspring Study. Ann Intern Med 128:524–533, 1998

Barnett A, Eff C, Leslie D, Pyke D: Diabetes in identical twins: a study of 200 pairs. Diabetologia 20:87–93, 1981

Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD: Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30:763–768, 1987

Gardner LI, Stern MP, Haffner SM, Gaskill SP, Hazuda HP, Relethford JH: Prevalence of diabetes in Mexican Americans: relationship to percent of gene pool derived from native American sources. Diabetes 33:86–92, 1984

Lee ET, Howard BV, Savage PJ, Cowan LD, Fabsitz RR, Oopvik AJ, Yeh J, Go O, Robbins DC, Welty TK: Diabetes and impaired glucose tolerance in three American Indian populations aged 45–74 years: the Strong Heart Study. Diabetes Care 18:599–610, 1995

Harlan LC, Harlan WR, Landis JR, Goldstein NG: Factors associated with glucose tolerance in adults in the United States. Am J Epidemiol 126:674–684, 1987

Morris RD, Rimm DL, Hartz AJ, Kalkoff RK, Rimm AA: Obesity and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32,662 adult white women. Am J Epidemiol 130:112–121, 1989

Meigs JB, Cupples LA, Wilson PWF: Parental transmission of type 2 diabetes mellitus: the Framingham Offspring Study. Diabetes 49:2201–2207, 2000

Winter WE, Nakamura M, House DV: Monogenic diabetes mellitus in youth: the MODY syndromes. Endocrinol Metab Clin North Am 28:765–785, 1999

Cook JTE, Shields DC, Page RCL, Levy JC, Hattersley AT, Shaw JAG, Neil HAW, Wainscoat JS, Turner RC: Segregation analysis of NIDDM in Caucasian families. Diabetologia 37:1231–1240, 1994

Elbein SC, Hoffman MD, Bragg KL, Mayorga RA: The genetics of NIDDM: an update (Review). Diabetes Care 17:1523–1533, 1994

DeFronzo RA: Lilly Lecture 1987: The triumvirate: beta-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667–687, 1988

Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44:1121–1125, 1995

Stern MP, Mitchell BD, Blangero J, Reinhart L, Krammerer CM, Harrison CR, Shipman PA, O’Connell P, Frazier ML, MacCluer JW: Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes 45:563–568, 1996

Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES: The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76–80, 2000

Knowler WC, Bennett PH, Hamman RF, Miller M: Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497–505, 1978

Elbein SC, Hoffman MD, Teng K, Leppert MF, Hasstedt SJ: A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 48:1175–1182, 1999

Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, Morrison VA, Wapelhorst B, Spielman RS, Gogolin-Ewens KJ, Shepard JM, Williams SR, Risch N, Hinds D, Iwasaki N, Ogata M, Omori Y, Petzold C, Rietzch H, Schroder HE, Schulze J, Cox NJ, Menzel S, Boriraj VV, Chen X, Lim LR, Lindner T, Mereu LE, Wang Y-Q, Xiang K, Yamagata K, Yang Y, Bell GI: A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13:161–166, 1996

Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D, Foroud T, Kobes S, Baier L, Burns DK, Almasy L, Blangero J, Garvey WT, Bennett PH, Knowler WC: An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 63:1130–1138, 1998

Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O’Connell P, Stern MP: Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 64:1127–1140, 1999

Cox NJ, Frigge M, Nicolae DL, Concannon P, Hanis CL, Bell GI, Kong A: Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 21:213–215, 1999

Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froguel P: Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21–q24. Am J Hum Genet 67:1470–1480, 2000

McCarthy M, Hattersley A, Walker M, Hitman G, Levy J, O’Rahilly S, Lathrop M, Simecek N, Wishart M, Dhillon R, Prestwich P, Fletcher C, Jones E, Frayling TM, Rao S, Bennett A, Menzel S: The British Diabetic Association Warren type 2 diabetes sibpair repository: interim report on a genome-wide scan for linkage in 439 European sibpair families (Abstract). Diabetes 49 (Suppl. 1):A199, 2000

Permutt MA, Wasson JC, Suarez BK, Lin J, Thomas J, Meyer J, Lewitzky S, Rennich JS, Parker A, DuPrat L, Maruti S, Chayen S, Glaser B: A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes 50:681–685, 2001

Parker A, Meyer J, Lewitzky S, Rennich JS, Chan G, Thomas JD, Orho-Melander M, Lehtovirta M, Forsblom C, Hyrkko A, Carlsson M, Lindgren C, Groop LC: A gene conferring susceptibility to type 2 diabetes in conjunction with obesity is located on chromosome 18p11. Diabetes 50:675–680, 2001

Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS: New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 46:876–881, 1997

Klupa T, Malecki MT, Pezzolesi M, Ji L, Curtis S, Langefeld CD, Rich SS, Warram JH, Krolewski AS: Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2. Diabetes 49:2212–2216, 2000

Ghosh S, Watanabe RM, Hauser ER, Valle T, Magnuson VL, Erdos MR, Langefeld CD, Balow J Jr, Ally DS, Kohtamaki K, Chines P, Birznieks G, Kaleta HS, Musick A, Te C, Tannenbaum J, Eldridge W, Shapiro S, Martin C, Witt A, So A, Chang J, Shurtleff B, Porter R, Kudelko K, Unni A, Segal L, Sharaf R, Blaschak-Harvan J, Eriksson J, Tenkula t, Vidgren G, Ehnholm C, Tuomilehto-Wolf E, Hagopian W, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M: Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A 96:2198–2203, 1999

Ehm MG, Karnoub MC, Sakul H, Gottschalk K, Holt DC, Weber JL, Vaske D, Briley D, Briley L, Kopf J, McMillen P, Nguyen Q, Reisman M, Lai EH, Joslyn G, Shepherd NS, Bell C, Wagner MJ, Burns DK: Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet 66:1871–1881, 2000

Bektas A, Suprenant ME, Wogan LT, Plengvidhya N, Rich SS, Warram JH, Krolewski AS, Doria A: Evidence of a novel type 2 diabetes locus 50 cM centromeric to NIDDM2 on chromosome 12q. Diabetes 48:2246–2251, 1999

Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD, Ally DS, Mohlke KL, Silander K, Kohtamaki K, Chines P, Balow Jr J, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales-Mena A, Musick A, Musick T, Pfahl C, Porter R, Rayman JB, Rha D, Segal L, Shapiro S, Sharaf R, Shurtleff B, So A, Tannenbaum J, Te C, Tovar J, Unni A, Welch C, Whiten R, Witt A, Blaschak-Harvan J, Douglas JA, Duren WL, Epstein MP, Fingerlin TE, Kaleta HS, Lange EM, Li C, McEachin RC, Stringham HM, Trager E, White PP, Eriksson J, Toivanen L, Vidgren G, Nylund SJ, Tuomilehto-Wolf E, Ross EH, Demirchyan E, Hagopian WA, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M: The Finland-United States Investigation of Non-Insulin-Dependent Diabetes Mellitus Genetics (FUSION) Study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 67:1174–1185, 2000

Luo TH, Zhao Y, Li G, Luan WT, Zhao JJ, Chen JL, Huang W, Luo M: A genome-wide search for type II diabetes susceptibility genes in Chinese Hans. Diabetologia 44:501–506, 2001

Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M, O’Rahilly S, Frayling TM, Bell JI, Lathrop GM, Bennett A, Dhillon R, Fletcher C, Groves CJ, Jones E, Prestwich P, Simecek N, Rao PV, Wishart M, Foxon R, Howell S, Smedley D, Cardon LR, Menzel S, McCarthy MI: A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 69:553–569, 2001

Steinle N, Kazlauskaite R, Pollin TI, Hsueh WC, Mitchell BD, Shuldiner AR: Type 2 diabetes positional candidate genes on chromosome 1: studies of the lamin A/C gene in the Amish Family Diabetes Study (Abstract). Diabetes 50 (Suppl. 2):A236, 2001

Stern MP, Duggirala R, Mitchell BD, Reinhart LJ, Shivakumar S, Shipman PA, Uresandi OC, Benavides E, Blangero J, O’Connell P: Evidence for linkage of regions on chromosomes 6 and 11 to plasma glucose concentrations in Mexican Americans. Genome Res 6:724–734, 1996

Pratley RE, Thompson DB, Prochazka M, Baier L, Mott D, Ravussin E, Sakul H, Ehm MG, Burns DK, Foroud T, Garvey WT, Hanson RL, Knowler WC, Bennett PH, Bogardus C: An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest 101:1757–1764, 1998

Watanabe RM, Ghosh S, Langefeld CD, Valle TT, Hauser ER, Magnuson VL, Mohlke KL, Silander K, Ally DS, Chines P, Blaschak-Harvan J, Douglas JA, Duren WL, Epstein MP, Fingerlin TE, Kaleta HS, Lange EM, Li C, McEachin RC, Stringham HM, Trager E, White PP, Balow J Jr, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales-Mena A, Musick A, Musick T, Pfahl C, Porter R, Rayman JB, Rha D, Segal L, Shapiro S, Sharaf R, Shurtleff B, So A, Tannenbaum J, Te C, Tovar J, Unni A, Welch C, Whiten R, Witt A, Kohtamaki K, Ehnholm C, Eriksson J, Toivanen L, Vidgren G, Nylund SJ, Tuomilehto-Wolf E, Ross EH, Demirchyan E, Hagopian WA, Buchanan TA, Tuomilehto J, Bergman RN, Collins FS, Boehnke M: The Finland-United States Investigation of Non-Insulin-Dependent Diabetes Mellitus Genetics (FUSION) Study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet 67:1186–1200, 2000

Kannel WB, Feinleib M, McNamara JR, Garrison RJ, Castelli WP: An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 110:281–290, 1979

Weber JL, May PE: Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44:388–396, 1989

Yuan B, Vaske D, Weber JL, Beck J, Sheffield VC: Improved set of short-tandem-repeat polymorphisms for screening the human genome (Letter). Am J Hum Genet 60:459–460, 1997

World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)

Kannel WB, Sorlie P: Some health benefits of physical activity: the Framingham Study. Arch Intern Med 139:857–861, 1979

Nathan DM: Labile glycosylated hemoglobin contributes to hemoglobin A1 as measured by liquid chromatography or electrophoresis. Clin Chem 27:1261–1263, 1981

The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986, 1993

Almasy L, Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198–1211, 1998

Fulker DW, Cherny SS, Cardon LR: Multipoint interval mapping of quantitative trait loci, using sib pairs. Am J Hum Genet 56:1224–1233, 1995

Lander E, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241–247, 1995

Rich SS: Mapping genes in diabetes: genetic epidemiological perspective (Review). Diabetes 39:1315–1319, 1990

Ghosh S, Schork NJ: Genetic analysis of NIDDM: the study of quantitative traits (Review). Diabetes 45:1–14, 1996

Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038–1045, 1995

German MS, Wang J, Fernald AA, Espinosa R 3rd, Le Beau MM, Bell GI: Localization of the genes encoding two transcription factors, LMX1 and CDX3, regulating insulin gene expression to human chromosomes 1 and 13. Genomics 24:403–404, 1994

Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163–175, 2000

Gitelman BJ, Simpson NE: Regional mapping of the locus for hexokinase-1 (HK1) to 10p11 equals to q23 by gene dosage in human fibroblasts. Hum Genet 60:227–229, 1982

Mahtani MM, Widen E, Lehto M, Thomas J, McCarthy M, Brayer J, Bryant B, Chan G, Daly M, Forsblom C, Kanninen T, Kirby A, Kruglyak L, Munnelly K, Parkkonen M, Reeve-Daly MP, Weaver A, Brettin T, Duyk G, Lander ES, Groop LC: Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 14:90–94, 1996

Allison DB, Heo M, Kaplan N, Martin ER: Sibling-based tests of linkage and association for quantitative traits. Am J Hum Genet 64:1754–1763, 1999

Terwilliger JD, Shannon WD, Lathrop GM, Nolan JP, Goldin LR, Chase GA, Weeks DE: True and false positive peaks in genomewide scans: applications of length-biased sampling to linkage mapping. Am J Hum Genet 61:430–438, 1997

Campbell PJ, Carlson MG: Impact of obesity on insulin action in NIDDM. Diabetes 42:405–410, 1993

Elbein SC, Wegner K, Kahn SE: Reduced beta-cell compensation to the insulin resistance associated with obesity in members of Caucasian familial type 2 diabetic kindreds. Diabetes Care 23:221–227, 2000

Mitchell BD, Kammerer CM, Mahaney MC, Blangero J, Comuzzie AG, Atwood LD, Haffner SM, Stern MP, MacCluer JW: Genetic analysis of the IRS: pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vasc Biol 16:281–288, 1996

Kilpatrick ES: Glycated haemoglobin in the year 2000. J Clin Pathol 53:335–339, 2000

Paglia DE, Valentine WN, Baughan MA, Miller DR, Reed CF, McIntyre OR: An inherited molecular lesion of erythrocyte pyruvate kinase: identification of a kinetically aberrant isozyme associated with premature hemolysis. J Clin Invest 47:1929–1946, 1968